Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n−3 fatty acids
Open Access
- 1 June 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 79 (6) , 1190S-1198S
Abstract
Conjugated linoleic acid (CLA) and the long-chain polyunsaturated n−3 fatty acids have been shown in vivo and in vitro to reduce tumor growth. Tumor growth could occur by slowing or stopping cell replication (by interfering with transition through the cell cycle), increasing cell death (via necrosis and/or apoptosis), or both. The anticancer effects of fatty acids, shown in vivo, could also be mediated by effects on the host's immune system. Although it is widely recognized that n−3 fatty acids can alter immune and inflammatory responses, considerably less is known about CLA. For n−3 fatty acids, several candidate mechanisms have been proposed for their immune effects, including changes in 1) membrane structure and composition, 2) membrane-mediated functions and signals (eg, proteins, eicosanoids), 3) gene expression, and 4) immune development. Considerable work has been done that shows the potential importance of CLA as an anticancer treatment; however, many questions remain as to how this effect occurs. This review summarizes the CLA and cancer literature and then uses the evidence for the anticancer immune and tumor properties of the long-chain n−3 fatty acids docosahexaenoic and eicosapentaenoic acids to suggest future research directions for mechanistic studies on CLA and cancer.Keywords
This publication has 127 references indexed in Scilit:
- Influence of conjugated vs. conventional linoleic acid on liver metastasis and hepatic lipidperoxidation in BOP-induced pancreatic cancer in Syrian hamsterProstaglandins, Leukotrienes and Essential Fatty Acids, 2002
- Inhibition of stearoyl-CoA desaturase activity by the cis-9,trans-11 isomer and the trans-10,cis-12 isomer of conjugated linoleic acid in MDA-MB-231 and MCF-7 human breast cancer cellsBiochemical and Biophysical Research Communications, 2002
- In vitro studies on the relationship between polyunsaturated fatty acids and cancer: tumour or tissue specific effects?Progress in Lipid Research, 2002
- Activation of PPARgamma may mediate a portion of the anticancer activity of conjugated linoleic acidMedical Hypotheses, 2000
- The Hallmarks of CancerCell, 2000
- Dietary conjugated Linoleic acid modulation of phorbol ester skin tumor promotionNutrition and Cancer, 1996
- The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the dietCarcinogenesis, 1996
- Influence of Diets Containing Eicosapentaenoic or Docosahexaenoic Acid on Growth and Metastasis of Breast Cancer Cells in Nude MiceJNCI: Journal of the National Cancer Institute, 1995
- Feeding Conjugated Linoleic Acid to Animals Partially Overcomes Catabolic Responses Due to Endotoxin InjectionBiochemical and Biophysical Research Communications, 1994
- The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and functionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1984